1. Home
  2. OBT vs MYGN Comparison

OBT vs MYGN Comparison

Compare OBT & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orange County Bancorp Inc.

OBT

Orange County Bancorp Inc.

HOLD

Current Price

$38.06

Market Cap

457.5M

Sector

Finance

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$3.03

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBT
MYGN
Founded
1892
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
457.5M
444.2M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
OBT
MYGN
Price
$38.06
$3.03
Analyst Decision
Buy
Buy
Analyst Count
1
7
Target Price
$36.00
$7.64
AVG Volume (30 Days)
38.2K
2.0M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
2.12%
N/A
EPS Growth
34.82
N/A
EPS
1.87
N/A
Revenue
N/A
$771,400,000.00
Revenue This Year
$14.27
$6.86
Revenue Next Year
$7.99
$5.45
P/E Ratio
$20.29
N/A
Revenue Growth
N/A
2.33
52 Week Low
$23.25
$2.74
52 Week High
$40.10
$8.59

Technical Indicators

Market Signals
Indicator
OBT
MYGN
Relative Strength Index (RSI) 46.09 36.19
Support Level $35.90 $2.79
Resistance Level $38.53 $3.31
Average True Range (ATR) 0.81 0.17
MACD -0.13 0.08
Stochastic Oscillator 28.03 45.65

Price Performance

Historical Comparison
OBT
MYGN

About OBT Orange County Bancorp Inc.

Orange County Bancorp Inc is a community bank holding company providing commercial and consumer banking services to individuals, small businesses, and local governments. It operates through two segments: Banking and Wealth Management. The Banking segment, the primary revenue driver, offers loans such as commercial real estate, construction, commercial & industrial, multifamily, and residential mortgages, along with services like cash management, escrow, deposits, ATMs, and digital banking. The Wealth Management segment provides investment management, trust services (trustee, administrator, custodian), and financial planning and advisory services to individuals and institutions.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: